ADMA Biologics (ADMA) Short Interest Ratio & Short Volume $15.83 -0.56 (-3.42%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$15.94 +0.11 (+0.66%) As of 03/3/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ADMA Biologics Short Interest DataADMA Biologics (ADMA) has a short interest of 13.74 million shares, representing 6.04% of the float (the number of shares available for trading by the public). This marks a 4.25% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.8, indicating that it would take 5.8 days of the average trading volume of 2.33 million shares to cover all short positions.Current Short Interest13,740,000 sharesPrevious Short Interest13,180,000 sharesChange Vs. Previous Month+4.25%Dollar Volume Sold Short$218.47 millionShort Interest Ratio5.8 Days to CoverLast Record DateFebruary 15, 2025Outstanding Shares236,390,000 sharesShort Percent of Float6.04%Today's Trading Volume4,033,178 sharesAverage Trading Volume2,326,833 sharesToday's Volume Vs. Average173% Short Selling ADMA Biologics? Sign up to receive the latest short interest report for ADMA Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartADMA Short Interest Over TimeADMA Days to Cover Over TimeADMA Percentage of Float Shorted Over Time ADMA Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/15/202513,740,000 shares $218.47 million +4.3%6.0%5.8 $15.90 1/31/202513,180,000 shares $212.86 million -2.6%N/A4.9 $16.15 1/15/202513,530,000 shares $226.09 million -0.7%N/A4.6 $16.71 12/31/202413,620,000 shares $233.58 million +11.8%N/A3.9 $17.15 12/15/202412,180,000 shares $226.43 million -5.7%N/A3.2 $18.59 11/30/202412,910,000 shares $259.62 million -9.3%N/A2.6 $20.11 11/15/202414,240,000 shares $271.13 million -6.3%N/A2.8 $19.04 10/31/202415,200,000 shares $247.91 million -5.4%N/A2.9 $16.31 10/15/202416,070,000 shares $266.44 million -5.9%N/A3.1 $16.58 9/30/202417,080,000 shares $341.43 million +37.5%N/A3.6 $19.99 Get the Latest News and Ratings for ADMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ADMA Biologics and its competitors with MarketBeat's FREE daily newsletter. 9/15/202412,420,000 shares $224.68 million +30.7%N/A2.6 $18.09 8/31/20249,500,000 shares $164.45 million +5.3%N/A2.6 $17.31 8/15/20249,020,000 shares $158.66 million +3.1%N/A2.6 $17.59 7/31/20248,750,000 shares $107.45 million +5.7%N/A2.5 $12.28 7/15/20248,280,000 shares $110.87 million +13.9%N/A2.6 $13.39 6/30/20247,270,000 shares $81.28 million -23.0%N/A2.5 $11.18 6/15/20249,440,000 shares $100.35 million +2.5%N/A3.4 $10.63 5/31/20249,210,000 shares $87.96 million +9.1%N/A3.3 $9.55 5/15/20248,440,000 shares $76.80 million -3.2%N/A2.9 $9.10 4/30/20248,720,000 shares $56.85 million +7.5%N/A3.4 $6.52 4/15/20248,110,000 shares $48.50 million +11.3%N/A3.2 $5.98 3/31/20247,290,000 shares $48.11 million -8.8%N/A2.7 $6.60 3/15/20247,990,000 shares $47.86 million +18.9%N/A3 $5.99 2/29/20246,720,000 shares $36.02 million +9.3%N/A2.6 $5.36 2/15/20246,150,000 shares $33.21 million -10.1%N/A2.9 $5.40 1/31/20246,840,000 shares $35.50 million -14.8%N/A3.2 $5.19 1/15/20248,030,000 shares $40.07 million +19.0%N/A3.7 $4.99 12/31/20236,750,000 shares $30.51 million -13.6%N/A3.4 $4.52 12/15/20237,810,000 shares $32.80 million -10.2%N/A4.2 $4.20 11/30/20238,700,000 shares $32.19 million -6.3%N/A4.9 $3.70 11/15/20239,280,000 shares $35.26 million -3.1%N/A4.8 $3.80 10/31/20239,580,000 shares $32.38 million +3.9%N/A4.1 $3.38 10/15/20239,220,000 shares $29.60 million +3.3%N/A4.2 $3.21 9/30/20238,930,000 shares $31.97 million +2.8%N/A4.1 $3.58 9/15/20238,690,000 shares $32.41 million -1.9%N/A4.1 $3.73 8/31/20238,860,000 shares $34.11 million -1.7%N/A4 $3.85 8/15/20239,010,000 shares $40.91 million +8.4%N/A4.2 $4.54 7/31/20238,310,000 shares $34.49 million -2.4%N/A4.1 $4.15 7/15/20238,510,000 shares $30.38 million +2.7%N/A4.2 $3.57 6/30/20238,290,000 shares $30.59 million -19.8%N/A3.9 $3.69URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now 6/15/202310,340,000 shares $41.26 million -1.2%N/A4.6 $3.99 5/31/202310,460,000 shares $42.57 million -6.4%N/A4.4 $4.07 5/15/202311,170,000 shares $46.80 million -1.2%N/A4.6 $4.19 4/30/202311,310,000 shares $37.89 million -2.8%N/A5.1 $3.35 4/15/202311,640,000 shares $37.02 million -6.8%N/A4.9 $3.18 3/31/202312,490,000 shares $41.34 million +14.4%N/A5.1 $3.31 3/15/202310,920,000 shares $34.18 million +0.8%N/A4.4 $3.13 2/28/202310,830,000 shares $38.45 million -6.2%N/A3.8 $3.55 2/15/202311,550,000 shares $41.35 million -9.7%N/A3.9 $3.58 1/31/202312,790,000 shares $47.20 million +6.1%N/A3.8 $3.69 1/15/202312,050,000 shares $40.97 million -5.3%N/A3.7 $3.40 12/30/202212,720,000 shares $49.35 million +1.8%N/A4 $3.88 12/15/202212,500,000 shares $44.50 million -37.4%N/A3.7 $3.56 11/30/202219,980,000 shares $66.73 million -8.1%N/A6 $3.34 11/15/202221,740,000 shares $70.44 million -15.9%N/A7.2 $3.24 10/31/202225,860,000 shares $72.93 million +0.2%N/A9.1 $2.82 10/15/202225,820,000 shares $67.65 million -6.3%N/A9.5 $2.62 9/30/202227,560,000 shares $66.97 million +6.0%N/A10.4 $2.43 9/15/202225,990,000 shares $70.43 million -2.0%N/A9 $2.71 8/31/202226,520,000 shares $71.60 million -6.2%N/A9.8 $2.70 8/15/202228,270,000 shares $68.13 million -1.7%N/A10.7 $2.41 7/31/202228,760,000 shares $61.55 million +0.1%N/A11.1 $2.14 7/15/202228,730,000 shares $66.08 million +1.3%N/A10.2 $2.30 6/30/202228,360,000 shares $56.15 million +11.0%N/A9.8 $1.98 6/15/202225,540,000 shares $51.85 million +1.0%N/A8.1 $2.03 5/31/202225,300,000 shares $51.87 million +5.4%N/A9.3 $2.05 5/15/202224,010,000 shares $42.26 million +4.5%N/A9.2 $1.76 4/30/202222,980,000 shares $42.28 million +3.1%N/A9.1 $1.84 4/15/202222,300,000 shares $44.82 million +10.1%N/A9.3 $2.01 3/31/202220,250,000 shares $37.06 million +25.0%N/A8.8 $1.83 3/15/202216,200,000 shares $25.11 million +10.7%N/A8.2 $1.55 2/28/202214,640,000 shares $23.57 million +4.4%N/A7.4 $1.61 2/15/202214,020,000 shares $23.41 million +36.0%N/A7.2 $1.67 1/31/202210,310,000 shares $14.95 million +1.2%N/A4.6 $1.45 1/15/202210,190,000 shares $14.27 million -4.1%N/A4.5 $1.40 12/31/202110,620,000 shares $14.97 million +6.6%N/A4.1 $1.41 12/15/20219,960,000 shares $12.75 million -1.2%N/A4 $1.28 11/30/202110,080,000 shares $13.91 million -9.7%N/A4.1 $1.38 11/15/202111,160,000 shares $17.30 million -7.4%N/A3.5 $1.55 10/29/202112,050,000 shares $15.54 million +4.4%N/A3.5 $1.29 10/15/202111,540,000 shares $12.69 million +10.5%N/A3.5 $1.10 9/30/202110,440,000 shares $11.80 million -9.9%8.3%3.6 $1.13 9/15/202111,590,000 shares $13.91 million -5.2%9.2%3.7 $1.20 8/31/202112,220,000 shares $16.37 million -3.3%9.7%3.9 $1.34 8/13/202112,640,000 shares $18.83 million -5.1%10.0%4.9 $1.49 7/30/202113,320,000 shares $20.65 million +14.2%10.6%6.3 $1.55 7/15/202111,660,000 shares $17.26 million +14.8%9.2%1.8 $1.48 6/30/202110,160,000 shares $16.26 million -16.9%8.1%1.5 $1.60 6/15/202112,220,000 shares $21.75 million +11.4%9.7%1.8 $1.78 5/28/202110,970,000 shares $19.20 million -0.6%8.7%1.6 $1.75URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now 5/14/202111,040,000 shares $17.88 million -21.4%N/A1.6 $1.62 4/30/202114,050,000 shares $28.80 million +36.0%N/A1.9 $2.05 4/15/202110,330,000 shares $17.77 million +2.6%N/A2.9 $1.72 3/31/202110,070,000 shares $17.22 million +17.9%N/A2.8 $1.71 3/15/20218,540,000 shares $18.10 million +4.4%N/A2.3 $2.12 2/26/20218,180,000 shares $19.22 million -6.5%N/A2 $2.35 2/12/20218,750,000 shares $25.29 million -9.3%N/A2.2 $2.89 1/29/20219,650,000 shares $20.94 million -13.0%N/A2.6 $2.17 1/15/202111,090,000 shares $23.40 million -4.3%N/A3.4 $2.11 12/31/202011,590,000 shares $23.30 million -3.2%N/A4 $2.01 12/15/202011,970,000 shares $25.38 million +0.2%N/A3.8 $2.12 11/30/202011,950,000 shares $22.71 million -2.3%N/A4.1 $1.90 11/15/202012,230,000 shares $23.48 million -5.4%N/A3.8 $1.92 10/30/202012,930,000 shares $26.25 million -8.3%N/A2.7 $2.03 10/15/202014,100,000 shares $32.29 million +1.4%N/A2.2 $2.29 9/30/202013,910,000 shares $33.24 million +4.1%N/A2.2 $2.39 9/15/202013,360,000 shares $31.26 million +0.4%N/A2.3 $2.34 8/31/202013,310,000 shares $33.94 million +12.0%N/A2.3 $2.55 8/14/202011,880,000 shares $37.07 million +21.1%N/A2 $3.12 7/31/20209,810,000 shares $35.02 million +1.7%N/A2.3 $3.57 7/15/20209,650,000 shares $27.99 million +0.9%N/A3.5 $2.90 6/30/20209,560,000 shares $28.01 million +3.8%N/A3.6 $2.93 6/15/20209,210,000 shares $28.46 million -7.5%N/A3.3 $3.09 5/29/20209,960,000 shares $32.77 million +2.9%N/A3.2 $3.29 5/15/20209,680,000 shares $25.36 million +10.5%N/A3.3 $2.62 4/30/20208,760,000 shares $25.84 million +2.9%N/A2.9 $2.95 4/15/20208,510,000 shares $23.40 million +17.5%N/A3.2 $2.75 3/31/20207,240,000 shares $22.15 million +4.1%N/A2.9 $3.06 3/13/20206,958,500 shares $19.00 million +29.8%N/A2.4 $2.73 ADMA Short Interest - Frequently Asked Questions What is ADMA Biologics' current short interest? Short interest is the volume of ADMA Biologics shares that have been sold short but have not yet been closed out or covered. As of February 15th, investors have sold 13,740,000 shares of ADMA short. 6.04% of ADMA Biologics' shares are currently sold short. Learn More on ADMA Biologics' current short interest. What is a good short interest ratio for ADMA Biologics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADMA shares currently have a short interest ratio of 6.0. Learn More on ADMA Biologics's short interest ratio. Which institutional investors are shorting ADMA Biologics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ADMA Biologics: Group One Trading LLC, Citadel Advisors LLC, Tudor Investment Corp ET AL, Susquehanna International Group LLP, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ADMA Biologics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.04% of ADMA Biologics' floating shares are currently sold short. Is ADMA Biologics' short interest increasing or decreasing? ADMA Biologics saw a increase in short interest in February. As of February 15th, there was short interest totaling 13,740,000 shares, an increase of 4.2% from the previous total of 13,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ADMA Biologics' short interest compare to its competitors? 6.04% of ADMA Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ADMA Biologics: Genmab A/S (0.26%), Summit Therapeutics Inc. (24.86%), Viatris Inc. (2.36%), Intra-Cellular Therapies, Inc. (2.23%), Moderna, Inc. (12.38%), Dr. Reddy's Laboratories Limited (2.26%), Vaxcyte, Inc. (11.04%), Sarepta Therapeutics, Inc. (5.58%), Ascendis Pharma A/S (9.97%), Qiagen (1.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), MicroStrategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks. What does it mean to sell short ADMA Biologics stock? Short selling ADMA is an investing strategy that aims to generate trading profit from ADMA Biologics as its price is falling. ADMA shares are trading down $0.56 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ADMA Biologics? A short squeeze for ADMA Biologics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ADMA, which in turn drives the price of the stock up even further. How often is ADMA Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADMA, twice per month. The most recent reporting period available is February, 15 2025. More Short Interest Resources from MarketBeat Related Companies GMAB Short Squeeze SMMT Short Squeeze VTRS Short Squeeze ITCI Short Squeeze MRNA Short Squeeze RDY Short Squeeze PCVX Short Squeeze SRPT Short Squeeze ASND Short Squeeze QGEN Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADMA) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADMA Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ADMA Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADMA Stock Alerts